Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Cardiovasc Nurs. 2015 Jul-Aug;30(4):346–350. doi: 10.1097/JCN.0000000000000171

Table 1:

Characteristics of the sample (n=273)

Mean±SD, or n (%)
Patient Characteristics:
Age (years) 57.3±13.2
Male 167 (61.2%)
Non-Hispanic Caucasian 231 (84.6%)
Education level
 Less than high school 89 (32.6%)
 >High school but < college 122 (44.7%)
 College degree 62 (22.7%)
Body Mass Index (kg/m2) 31.0±7.4
Charlson Comorbidity Index (weighted) 2.3±1.4
Atrial Fibrillation 109 (39.9%)
Stage 3 Chronic Kidney Disease 40 (14.7%)
General Heart Failure Characteristics:
Time with Heart Failure in years: median [IQR] 4.2 [0.8–7.5]
NYHA Functional Class
 Class II 106 (38.8%)
 Class III 157 (57.5%)
 Class IV 10 (3.7%)
Heart Failure Etiology
 Non-ischemic 174 (63.6%)
 Ischemic 99 (36.3%)
Prescribed a β-blocker 246 (90.8%)
Prescribed an ACE-I or ARB 223 (81.6%)
Serum sodium (mEq/L) 137.8±3.3
Serum hematocrit (%) 39.0±5.8
Serum BUN-to-creatinine ratio (mg/dL:1) 20.2±9.5
Cardiac Biomechanics:
Left ventricular internal end-diastolic diameter (cm) 6.1±1.1
Left ventricular ejection fraction (%) 28.3%±12.4%
Pulmonary capillary wedge pressure (mm/Hg) 19.0±8.5
Right atrial pressure (mm/Hg) 9.6±5.5
Cardiac index (L/min/m2 by Fick equation) 2.1±0.5
Symptomatology:
Physical symptoms (HFSPS Score; 0–90) 24.6±16.7
Depression (PHQ9; 0–27) 7.2±6.1
Anxiety (BSI; 0–4) 0.53±0.63

Abbreviations: ACE-I, Angiotensin Converting Enzyme-Inhibitor; ARB, Angiotensin Receptor Blocker; BSI, Brief Symptom Inventory; HFSPS, Heart Failure Somatic Perception Scale; IQR, interquartile range; NYHA, New York Heart Association; PHQ9, Patient Health Questionnaire; SD, Standard Deviation